RevBio Gets FDA Approval to Expand Trial and CMS Reimbursement for Regenerative Bone Adhesive
RevBio, Inc. announced that it has received FDA approval to expand its ongoing clinical trial to use TETRANITE®, its bone adhesive biomaterial, for immediate cranial flap fixation. Additionally, the company has secured reimbursement coverage from the Centers for Medicare and…